The novel treatment of this peptide represents a significant advance in the care of type 2 diabetes. Distinct from existing medications, tirzepatide affects multiple pathways – glucagon-like peptide-1 (GLP-1) and https://tirzepatidepeptide981622.dbblog.net/15359241/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment